Intellectual Property

Intellectual property disputes take place on a daily basis in a variety of venues. From an employee’s right to a patent of company-developed products to patent wars between international companies for illegal use of a product/logo, the National Law Review is a great resource for updates on all things IP. The site covers litigation at the United States Patent and Trademark Office (USPTO) and the  Patent Trial and Board Appeals (PTAB), as well as cases in front of the International Trade Commission (ITC) for international patent disputes. The National Law Review covers cases heard by the Supreme Court of the United States (SCOTUS), or appeals which are now sitting in front of the patent-board on Inter partes review (IPR). Additionally, the National Law Review covers cases and decisions of the Federal Trade Commission (FTC).

Copyrights, patent infringement claims, trade secrets, false advertising claims, unfair competition, and intellectual property laws which govern patent-litigation, are all areas which the National Law Review covers, in detail for readers. Patent disputes don’t only occur in the United States. When international countries including the United Kingdom, Brazil, China, India, and the European Union get involved, international laws are also taken into consideration by the PTO. Additionally, information on how to obtain patent protection internationally is also available on the National Law Review.

Intellectual property news on the National Law Review spans from topics including biosimilars, domain name registration, generic top-level domains (gTLDs), drug patents, non-compete agreements, trade secrets, and other industry-related battles which ensue, are covered on the site. Visitors can read about the latest legislation, laws, and news, as it relates to patents and intellectual property in general. Further, visitors to the National Law Review are going to find the latest stories and litigation as it unfolds in front of patent courts across the land. From email and data retention policies, patent disputes over medical devices, cloud computing and artificial intelligence the National Law Review has the details and expert intellectual property litigation legal analysis readers count on.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization
Apr
26
2018
Supreme Court Rules Inter Partes Review is Constitutional, for Now McDermott Will & Emery
Apr
26
2018
Supreme Court Rules That PTAB Must Review In IPRs All Challenged Claims, Or None At All Proskauer Rose LLP
Apr
26
2018
Supreme Court Upholds Constitutionality of Inter Partes Review Proceeding, Leaving Intact System in Which Thousands of Patents Have Been Challenged Barnes & Thornburg LLP
Apr
26
2018
Overcoming Early Alice Rejections in Litigation Vedder Price
Apr
26
2018
Seventh Circuit Hands the Ball to State Supreme Court McDermott Will & Emery
Apr
26
2018
Fraudulent Lawsuit Allegations Insufficient to Maintain RICO Claim McDermott Will & Emery
Apr
26
2018
Who Is “Another” Depends on Who Else Is Named McDermott Will & Emery
Apr
26
2018
Incorporation by Reference Is Not a Substitute for a Specific Priority Claim Squire Patton Boggs (US) LLP
Apr
26
2018
In Face of Separation of Powers Challenge, Supreme Court Upholds Patent Office Inter Partes Review Proskauer Rose LLP
Apr
25
2018
No Estoppel-Based PGR Proceeding for Related Patent McDermott Will & Emery
Apr
25
2018
Waiver Leads to Double Tax Liability on Patent Royalties McDermott Will & Emery
Apr
25
2018
Cleaning Up Aseptic Packaging Patent Disputes McDermott Will & Emery
Apr
25
2018
Supreme Court Holds That the PTO Cannot Institute Review on Only Some of the Challenged Claims Foley & Lardner LLP
Apr
25
2018
PTAB May Disregard New Evidence Presented at Oral Argument McDermott Will & Emery
Apr
25
2018
Claim Term Cannot Be Uncoupled from Specification and Claim Language McDermott Will & Emery
Apr
25
2018
Federal Circuit Provides Guidance for Stereochemistry Claim Construction Mintz
Apr
25
2018
Oil States Energy Services, LLC v. Greene’s Energy Group, LLC, et al.: The Magic Happens Around the Word “Franchise” Squire Patton Boggs (US) LLP
Apr
25
2018
Prima Facie Obviousness: Much Ado “Abut” Ranges McDermott Will & Emery
Apr
25
2018
Federal Circuit to PTAB: Explain Yourself McDermott Will & Emery
Apr
25
2018
A Book Holder Is Not a Camera Holder McDermott Will & Emery
Apr
25
2018
Earlier Disclosure Conveys Possession of Invention, Is Not Invalidating Reference McDermott Will & Emery
Apr
25
2018
Claim Differentiation Cannot Be Used to Broaden Narrowly Described Invention McDermott Will & Emery
Apr
25
2018
Terminal Disclaimer Does Not Establish Claim Preclusion McDermott Will & Emery
Apr
25
2018
Supreme Court Signals Full Steam Ahead for Challenging Patents in AIA Proceedings in Back-to-Back Oil States and SAS Institute Decisions Brinks Gilson & Lione
Apr
25
2018
Mic Drop: PTAB Not Bound by Prior Federal Circuit Decisions McDermott Will & Emery
Apr
24
2018
Supreme Court Decides Oil States – Inter Partes Review Does Not Violate Article III or the 7th Amendment Schwegman, Lundberg & Woessner, P.A.
Apr
24
2018
Supreme Court Upholds the Constitutionality of Inter Partes Reviews Foley & Lardner LLP
Apr
24
2018
U.S. Patent Case Update: IPR Proceedings K&L Gates
Apr
24
2018
Supreme Court Inter Parties Review Decision - SAS INSTITUTE INC. v. IANCU Womble Bond Dickinson (US) LLP
Apr
24
2018
Supreme Court Upholds Constitutionality Of IPRs In Oil States Foley & Lardner LLP
Apr
24
2018
Is the International Trade Commission the Most Patent-Friendly Venue with a Complainant Success Rate Near 90%? Foley & Lardner LLP
Apr
23
2018
USPTO Updates Examination Procedure Pertaining To Subject Matter Eligibility Brinks Gilson & Lione
Apr
23
2018
USPTO Issues Patent Eligibility Examination Guidance Under Berkheimer Foley & Lardner LLP
Apr
20
2018
USPTO Memorandum Seeks to Clarify “Inventive Concept” Requirement Schwegman, Lundberg & Woessner, P.A.
Apr
19
2018
Personalized Medicine Gets a Boost from Federal Circuit’s Vanda Pharma Decision Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins